Immunic | VTL - Selling And Administration Expenses


Immunic reported $3.45M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
BioMarin Pharmaceutical USD 258.28M 63.92M Mar/2026
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.43M 222K Mar/2026
CSL USD 1.23B 498M Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Grifols EUR 320.45M 12.65M Dec/2025
Immunic USD 3.45M 451K Dec/2025
Insmed USD 247.26M 34.78M Mar/2026
Omeros USD 11.32M 2.48M Sep/2024
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Ultragenyx Pharmaceutical USD 88M 1000K Mar/2026
United Therapeutics USD 156.6M 34M Mar/2026
Xoma USD 11M 2.54M Jun/2024